Vulcanescu Dan Dumitru, Bagiu Iulia Cristina, Avram Cecilia Roberta, Oprisoni Licinia Andrada, Tanasescu Sonia, Sorescu Teodora, Susan Razvan, Susan Monica, Sorop Virgiuliu Bogdan, Diaconu Mircea Mihai, Dragomir Tiberiu Liviu, Harich Octavia Oana, Horhat Razvan Mihai, Dinu Stefania, Horhat Florin George
Department of Microbiology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Multidisciplinary Research Center on Antimicrobial Resistance (MULTI-REZ), Microbiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Antibiotics (Basel). 2024 Dec 14;13(12):1219. doi: 10.3390/antibiotics13121219.
The COVID-19 pandemic has intensified concerns over bacterial infections and antimicrobial resistance, particularly in Romania. This systematic review explores bacterial infection patterns and resistance during the pandemic to address critical gaps in knowledge. A systematic review, following PRISMA guidelines, was conducted using databases such as PubMed and Scopus, focusing on studies of bacterial infections from 2020 to 2022. Articles on bacterial infections in Romanian patients during the pandemic were analyzed for demographic data, bacterial trends, and resistance profiles. A total of 87 studies were included, detailing over 20,000 cases of bacterial infections. The review found that Gram-negative bacteria, particularly and , were the most frequently identified pathogens, alongside Gram-positive and spp. Multidrug resistance (MDR) was noted in 24% of the reported strains, with common resistance to carbapenems and cephalosporins. The pandemic has amplified the complexity of managing bacterial infections, particularly in critically ill patients. The rise in MDR bacteria underscores the need for stringent antimicrobial stewardship and infection control measures. Continuous monitoring of bacterial trends and resistance profiles will be essential to improve treatment strategies in post-pandemic healthcare settings.
新冠疫情加剧了人们对细菌感染和抗菌药物耐药性的担忧,在罗马尼亚尤其如此。本系统综述探讨了疫情期间的细菌感染模式和耐药情况,以填补关键的知识空白。按照PRISMA指南,利用PubMed和Scopus等数据库进行了一项系统综述,重点关注2020年至2022年期间的细菌感染研究。对疫情期间罗马尼亚患者细菌感染的文章进行了分析,以获取人口统计学数据、细菌趋势和耐药情况。共纳入87项研究,详细记录了20000多例细菌感染病例。该综述发现,革兰氏阴性菌,尤其是[具体菌名1]和[具体菌名2],与革兰氏阳性菌[具体菌名3]和[具体菌名4]属一样,是最常鉴定出的病原体。在所报告的菌株中,24%存在多重耐药(MDR),对碳青霉烯类和头孢菌素类普遍耐药。疫情加剧了管理细菌感染的复杂性,尤其是在重症患者中。MDR细菌的增加凸显了严格的抗菌药物管理和感染控制措施的必要性。持续监测细菌趋势和耐药情况对于改善疫情后医疗环境中的治疗策略至关重要。